Fig. 6From: Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndromeSummary figure. Consumption of TXN affects the composition of the gut microbial community, reducing Oscillibacter spp. (known to produce TLR agonists such as flagellin and lipoproteins), which in turn leads to a reduction of metabolically damaging insulin resistance associated adipose tissue macrophages (IR-ATMs)Back to article page